Literature DB >> 33835307

The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma.

Kyle P D'mello1, Lei Zhao2, Erin C Kaser1, Ziwen Zhu3, Huaping Xiao1,4, Mark R Wakefield3, Qian Bai3, Yujiang Fang5,6.   

Abstract

Non-Hodgkin's lymphoma is a relatively common cancer with malignant tendencies. Although there is no current cure for the disease, research has been successful in figuring out the mechanisms of how the disease progresses, however, there is still a lot of unknowns, and more research must be done to find the ultimate cause of the disease. Interleukins and various cytokines play unique roles in the development of cancer. This review article summarizes the pathophysiology between certain interleukins and non-Hodgkin's lymphoma. Although TNF-α is not an interleukin, the article examines TNF-α due to its high correspondence with cancer. The article also describes a promising immunotherapy for the disease, while looking at immunotherapies that have been successful in other types of cancer and disease.

Entities:  

Keywords:  IL; Interleukins; Lymphoma; Non-Hodgkin’s lymphoma; TNF-α

Year:  2021        PMID: 33835307     DOI: 10.1007/s12032-021-01504-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  33 in total

Review 1.  Interleukins: biological properties and therapeutic potential.

Authors:  R E Elmslie; S W Dow; G K Ogilvie
Journal:  J Vet Intern Med       Date:  1991 Sep-Oct       Impact factor: 3.333

Review 2.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

Review 3.  The role of IL-7 in Immunity and Cancer.

Authors:  Jack Lin; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Vivi A Ding; Qian Bai; Yujiang Fang
Journal:  Anticancer Res       Date:  2017-03       Impact factor: 2.480

4.  [Considerations on the surgical therapy of hallux valgus].

Authors:  M Parmiani; B Esposito; E Sgarbi
Journal:  Policlinico Chir       Date:  1967-06

Review 5.  The Role of Interleukin-9 in Cancer.

Authors:  Jacob E Lee; Ziwen Zhu; Qian Bai; Tucker J Brady; Huaping Xiao; Mark R Wakefield; Yujiang Fang
Journal:  Pathol Oncol Res       Date:  2019-04-23       Impact factor: 3.201

Review 6.  The role of IL-21 in immunity and cancer.

Authors:  Matthew R Davis; Ziwen Zhu; Dwayne M Hansen; Qian Bai; Yujiang Fang
Journal:  Cancer Lett       Date:  2015-01-06       Impact factor: 8.679

Review 7.  Interleukins and cancer immunotherapy.

Authors:  Takayuki Yoshimoto; Noriko Morishima; Masae Okumura; Yukino Chiba; Mingli Xu; Junichiro Mizuguchi
Journal:  Immunotherapy       Date:  2009-09       Impact factor: 4.196

Review 8.  The role of IL-37 in cancer.

Authors:  Vivi A Ding; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Med Oncol       Date:  2016-06-01       Impact factor: 3.064

Review 9.  The role of IL-11 in immunity and cancer.

Authors:  Dixon H Xu; Ziwen Zhu; Mark R Wakefield; Huaping Xiao; Qian Bai; Yujiang Fang
Journal:  Cancer Lett       Date:  2016-01-27       Impact factor: 8.679

Review 10.  The role of IL-29 in immunity and cancer.

Authors:  Noah E Kelm; Ziwen Zhu; Vivi A Ding; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Crit Rev Oncol Hematol       Date:  2016-08-10       Impact factor: 6.312

View more
  1 in total

1.  IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma.

Authors:  Qiuhua Zhu; Huan Li; Shanshan Zheng; Bin Wang; Mingjie Li; Wenbin Zeng; Lanlan Zhou; Zebing Guan; Hong Wang; Yanan Liu; Yanmin Gao; Shiqiu Qiu; Chaolun Chen; Shimei Yang; Yuemei Yuan; Hanling Zhang; Guanqiao Ruan; Xueyi Pan
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.